NYSE:EVH Evolent Health (EVH) Stock Forecast, Price & News $26.81 -0.02 (-0.07%) (As of 09/26/2023 ET) Add Compare Share Share Today's Range$26.68▼$27.3250-Day Range$25.00▼$31.4052-Week Range$21.83▼$37.98Volume1.55 million shsAverage Volume1.05 million shsMarket Capitalization$3.04 billionP/E RatioN/ADividend YieldN/APrice Target$46.56 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Evolent Health MarketRank™ ForecastAnalyst RatingModerate Buy2.88 Rating ScoreUpside/Downside73.6% Upside$46.56 Price TargetShort InterestBearish6.38% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.59Based on 4 Articles This WeekInsider TradingSelling Shares$1.02 M Sold Last QuarterProj. Earnings Growth190.32%From $0.31 to $0.90 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.16 out of 5 starsComputer And Technology Sector345th out of 578 stocksManagement Services Industry4th out of 6 stocks 3.4 Analyst's Opinion Consensus RatingEvolent Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 7 buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $46.56, Evolent Health has a forecasted upside of 73.6% from its current price of $26.81.Amount of Analyst CoverageEvolent Health has only been the subject of 1 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted6.38% of the outstanding shares of Evolent Health have been sold short.Short Interest Ratio / Days to CoverEvolent Health has a short interest ratio ("days to cover") of 6.2.Change versus previous monthShort interest in Evolent Health has recently decreased by 1.36%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldEvolent Health does not currently pay a dividend.Dividend GrowthEvolent Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EVH. Previous Next 2.5 News and Social Media Coverage News SentimentEvolent Health has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Evolent Health this week, compared to 2 articles on an average week.Search Interest1 people have searched for EVH on MarketBeat in the last 30 days. MarketBeat FollowsOnly 2 people have added Evolent Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Evolent Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,016,079.00 in company stock.Percentage Held by InsidersOnly 3.30% of the stock of Evolent Health is held by insiders. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Evolent Health are expected to grow by 190.32% in the coming year, from $0.31 to $0.90 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Evolent Health is -38.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Evolent Health is -38.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEvolent Health has a P/B Ratio of 3.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Evolent Health (NYSE:EVH) StockEvolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, offers clinical and administrative solutions to payers and providers in the United States. The company operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology, cardiology, and musculoskeletal markets; physician-oriented total cost of care solutions; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.Read More EVH Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EVH Stock News HeadlinesSeptember 25, 2023 | finance.yahoo.comEvolent Health, Inc. (NYSE:EVH): Are Analysts Optimistic?September 24, 2023 | americanbankingnews.comM3 (OTCMKTS:MTHRF) versus Evolent Health (NYSE:EVH) Critical ComparisonSeptember 26, 2023 | Legacy Research (Ad)WARNING: Mandatory U.S. Dollar Recall is Weeks AwayIf you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.September 22, 2023 | msn.com30 US States Pause Medicaid Disenrollment Due To Technical GlitchAugust 24, 2023 | finance.yahoo.comEvolent saves Medicare more than $55 million through its Medicare Shared Savings Program ACOAugust 14, 2023 | msn.comGuggenheim Reiterates Evolent Health Inc - (EVH) Buy RecommendationAugust 4, 2023 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Evolent Health (EVH), Karuna Therapeutics (KRTX)August 4, 2023 | insidermonkey.comEvolent Health, Inc. (NYSE:EVH) Q2 2023 Earnings Call TranscriptSeptember 26, 2023 | Legacy Research (Ad)WARNING: Mandatory U.S. Dollar Recall is Weeks AwayIf you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.August 3, 2023 | finanznachrichten.deEvolent Health: Evolent Announces Second Quarter 2023 ResultsAugust 3, 2023 | finance.yahoo.comEvolent Announces Second Quarter 2023 ResultsAugust 3, 2023 | finance.yahoo.comEvolent Health (EVH) Surpasses Q2 Earnings and Revenue EstimatesAugust 3, 2023 | finance.yahoo.comEvolent Health (EVH) Q2 2023 Earnings Call TranscriptJuly 26, 2023 | finance.yahoo.comEvolent welcomes Toyin Ajayi to its Board of DirectorsJuly 20, 2023 | markets.businessinsider.comRBC Capital Keeps Their Buy Rating on Evolent Health (EVH)July 19, 2023 | msn.comEvolent Health: Business Economics Still Appealing, Reiterate BuyJuly 18, 2023 | markets.businessinsider.comTruist Financial Reaffirms Their Hold Rating on Evolent Health (EVH)July 13, 2023 | finance.yahoo.comEvolent to Release Second Quarter Financial Results on Wednesday, August 2, 2023July 11, 2023 | finance.yahoo.comEvolent Health announces focus on value-based specialty care with rebrand, unification of all solutions under "Evolent"July 7, 2023 | markets.businessinsider.comEvolent Health (EVH) Receives a Buy from RBC CapitalJuly 3, 2023 | finance.yahoo.comWe Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)June 27, 2023 | msn.comGuggenheim Maintains Evolent Health Inc - (EVH) Buy RecommendationJune 26, 2023 | markets.businessinsider.comAnalyst Ratings for Evolent HealthJune 16, 2023 | fool.comEvolent Health (NYSE: EVH)June 16, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Raffles Medical Group (RAFLF), Evolent Health (EVH)May 24, 2023 | msn.comRBC Capital Reiterates Evolent Health Inc - (EVH) Outperform RecommendationMay 22, 2023 | finance.yahoo.comEvolent Health, Inc.'s (NYSE:EVH) Intrinsic Value Is Potentially 76% Above Its Share PriceSee More Headlines Receive EVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter. Email Address EVH Company Calendar Last Earnings8/02/2023Today9/26/2023Next Earnings (Estimated)11/01/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Management services Sub-IndustryN/A SectorComputer and Technology Current SymbolNYSE:EVH CUSIPN/A CIK1628908 Webwww.evolenthealth.com Phone(571) 389-6000Fax571-389-6001Employees5,100Year FoundedN/APrice Target and Rating Average Stock Price Forecast$46.56 High Stock Price Forecast$59.00 Low Stock Price Forecast$32.00 Forecasted Upside/Downside+74.0%Consensus RatingModerate Buy Rating Score (0-4)2.88 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)($0.70) Trailing P/E RatioN/A Forward P/E Ratio86.32 P/E GrowthN/ANet Income$-19,160,000.00 Net Margins-3.89% Pretax Margin-10.85% Return on Equity8.07% Return on Assets3.60% Debt Debt-to-Equity Ratio0.58 Current Ratio1.07 Quick Ratio1.07 Sales & Book Value Annual Sales$1.35 billion Price / Sales2.24 Cash Flow$1.49 per share Price / Cash Flow17.95 Book Value$8.60 per share Price / Book3.11Miscellaneous Outstanding Shares113,240,000Free Float109,507,000Market Cap$3.03 billion OptionableOptionable Beta1.52 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Seth Barrie Blackley (Age 44)Co-Founder, CEO & Director Comp: $1.79MMr. Dan McCarthy (Age 38)CEO of New Century Health & Pres Comp: $1.29MMr. John Paul Johnson (Age 39)Chief Financial Officer Comp: $994.22kMr. Jonathan David Weinberg J.D. (Age 55)Chief Legal Officer, Gen. Counsel & Sec. Comp: $696.07kMs. Emily Rafferty (Age 40)Chief Operating Officer Mr. Aammaad Shams (Age 39)Chief Accounting Officer Mr. Seth R. FrankVP of Investor RelationsMs. Jessica SomersSr. VP of Corp. Devel.Ms. Kali BeyahChief People & Brand OfficerDr. John Tam M.D.Chief Strategy OfficerMore ExecutivesKey CompetitorsEngageSmartNYSE:ESMTCommvault SystemsNASDAQ:CVLTHaywardNYSE:HAYWBlackBerryNYSE:BBCalixNYSE:CALXView All CompetitorsInsiders & InstitutionsAlberta Investment Management CorpSold 5,085 shares on 8/24/2023Ownership: 0.080%Comerica BankBought 26,305 shares on 8/22/2023Ownership: 0.023%California State Teachers Retirement SystemBought 18,532 shares on 8/21/2023Ownership: 0.110%Osaic Holdings Inc.Sold 2,188 shares on 8/21/2023Ownership: 0.002%Legato Capital Management LLCBought 8,779 shares on 8/18/2023Ownership: 0.028%View All Insider TransactionsView All Institutional Transactions EVH Stock - Frequently Asked Questions Should I buy or sell Evolent Health stock right now? 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EVH shares. View EVH analyst ratings or view top-rated stocks. What is Evolent Health's stock price forecast for 2023? 8 analysts have issued twelve-month price objectives for Evolent Health's shares. Their EVH share price forecasts range from $32.00 to $59.00. On average, they predict the company's stock price to reach $46.56 in the next twelve months. This suggests a possible upside of 74.0% from the stock's current price. View analysts price targets for EVH or view top-rated stocks among Wall Street analysts. How have EVH shares performed in 2023? Evolent Health's stock was trading at $28.08 at the beginning of the year. Since then, EVH stock has decreased by 4.7% and is now trading at $26.76. View the best growth stocks for 2023 here. When is Evolent Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023. View our EVH earnings forecast. How were Evolent Health's earnings last quarter? Evolent Health, Inc. (NYSE:EVH) announced its quarterly earnings results on Wednesday, August, 2nd. The technology company reported $0.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.01) by $0.07. The technology company had revenue of $469.14 million for the quarter, compared to analyst estimates of $462.51 million. Evolent Health had a positive trailing twelve-month return on equity of 8.07% and a negative net margin of 3.89%. What ETFs hold Evolent Health's stock? ETFs with the largest weight of Evolent Health (NYSE:EVH) stock in their portfolio include Fidelity Digital Health ETF (FDHT), Harbor Corporate Culture Small Cap ETF (HAPS), Fidelity Disruptive Medicine ETF (FMED), Harbor Small Cap Explorer ETF (QWST).LeaderShares Activist Leaders ETF (ACTV) and What guidance has Evolent Health issued on next quarter's earnings? Evolent Health updated its third quarter 2023 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $500.00 million-$520.00 million, compared to the consensus revenue estimate of $522.29 million. What is Seth Blackley's approval rating as Evolent Health's CEO? 12 employees have rated Evolent Health Chief Executive Officer Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among the company's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Evolent Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET), Chipotle Mexican Grill (CMG), Ford Motor (F), Cisco Systems (CSCO) and Heron Therapeutics (HRTX). When did Evolent Health IPO? (EVH) raised $150 million in an IPO on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers. What is Evolent Health's stock symbol? Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH." Who are Evolent Health's major shareholders? Evolent Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.74%), Bellevue Group AG (3.05%), Granahan Investment Management LLC (2.57%), William Blair Investment Management LLC (2.37%), Eventide Asset Management LLC (2.33%) and Dimensional Fund Advisors LP (2.17%). Insiders that own company stock include Cheryl Scott, Daniel Joseph Mccarthy, Diane Holder, Frank J Williams, Frank J Williams, John Paul Johnson, Jonathan Weinberg, Mary Bridget Duffy, Seth Blackley, Simon Maisey and Steve Tutewohl. View institutional ownership trends. How do I buy shares of Evolent Health? Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Evolent Health's stock price today? One share of EVH stock can currently be purchased for approximately $26.76. How much money does Evolent Health make? Evolent Health (NYSE:EVH) has a market capitalization of $3.03 billion and generates $1.35 billion in revenue each year. The technology company earns $-19,160,000.00 in net income (profit) each year or ($0.70) on an earnings per share basis. How many employees does Evolent Health have? The company employs 5,100 workers across the globe. How can I contact Evolent Health? Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The official website for the company is www.evolenthealth.com. The technology company can be reached via phone at (571) 389-6000, via email at investorrelations@evolenthealth.com, or via fax at 571-389-6001. This page (NYSE:EVH) was last updated on 9/26/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolent Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.